Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
Status unconfirmed · Phase 3
Conditions studied: Brain and Central Nervous System Tumors
In brief
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. It is not yet known if the addition of photodynamic therapy to combined therapy with surgery, radiation therapy, and chemotherapy is more effective than combined therapy alone for supratentorial gliomas. PURPOSE: Randomized phase III trial to study the effectiveness of surgery, radiation therapy, and chemotherapy with or without photodynamic therapy in treating patients who have newly diagnosed or recurrent malignant supratentorial gliomas.
Key facts
- Study ID
- NCT00003788
- Run by
- Colorado Health Foundation
- People needed
- 270
- Starts
- 1998-04-01
- Last updated by the study team
- 2013-11-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Rocky Mountain Neurological Associates — Englewood, Colorado, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Western Pennsylvania Hospital — Pittsburgh, Pennsylvania, United States
- St. Michael's Hospital-Annex — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.